发明授权
US07625888B2 Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
失效
稠合三唑衍生物作为二肽基肽酶-IV抑制剂用于治疗或预防糖尿病
- 专利标题： Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
- 专利标题（中）： 稠合三唑衍生物作为二肽基肽酶-IV抑制剂用于治疗或预防糖尿病
-
申请号： US11660130申请日： 2005-08-19
-
公开(公告)号： US07625888B2公开(公告)日： 2009-12-01
- 发明人: Ann E. Weber , Wallace T. Ashton
- 申请人： Ann E. Weber , Wallace T. Ashton
- 申请人地址： US NJ Rahway
- 专利权人： Merck & Co., Inc.
- 当前专利权人： Merck & Co., Inc.
- 当前专利权人地址： US NJ Rahway
- 代理商 Philippe L. Durette; Catherine D. Fitch
- 国际申请： PCT/US2005/029591 WO 20050819
- 国际公布： WO2006/023750 WO 20060302
- 主分类号： C07D471/00
- IPC分类号： C07D471/00 ; C07D487/00 ; A61K31/44 ; A61K31/495 ; A61K31/55 ; A61P3/00
摘要：
The present invention is directed to novel fused triazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
公开/授权文献
信息查询
